Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans
- PMID: 16237395
- DOI: 10.1038/sj.npp.1300916
Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans
Abstract
This study examined D-amphetamine (D-AMPH)-induced displacements of [18F] fallypride in striatal and extrastriatal regions and the correlations of these displacements with cognition, affect, and sensation-seeking behavior. In all, 14 normal subjects, six females and eight males (ages 21-32, mean age 25.9 years), underwent positron emission tomography (PET) with [18F]fallypride before and 3 h after a 0.43 mg/kg oral dose of D-AMPH. Levels of dopamine (DA) D2 receptor density were calculated with the reference region method of Lammerstma. Percent displacements in striatal and extrastriatal regions were calculated for the caudate, putamen, ventral striatum, medial thalamus, amygdala, substantia nigra, and temporal cortex. Correlations of changes in cognition, affect, and sensation seeking with parametric images of D-AMPH-induced DA release were computed. Significant displacements were seen in the caudate, putamen, ventral striatum substantia nigra, and temporal cortex with a trend level change in the amygdala. Greatest displacements were seen in striatal subdivisions-5.6% in caudate, 11.2% in putamen, 7.2% in ventral striatum, and 6.6% in substantia nigra. Lesser decrements were seen in amygdala-4.4%, temporal cortex-3.7%, and thalamus-2.8%. Significant clusters of correlations of regional DA release with cognition and sensation-seeking behavior were observed. The current study demonstrates that [18F]fallypride PET studies using oral D-AMPH (0.43 mg/kg) can be used to study D-AMPH-induced DA release in the striatal and extrastriatal regions in humans, and their relationship with cognition and sensation-seeking behavior.
Similar articles
-
Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans.Synapse. 2008 Jun;62(6):399-408. doi: 10.1002/syn.20506. Synapse. 2008. PMID: 18361438 Clinical Trial.
-
Estimation of baseline dopamine D2 receptor occupancy in striatum and extrastriatal regions in humans with positron emission tomography with [18F] fallypride.Biol Psychiatry. 2008 Jan 15;63(2):241-4. doi: 10.1016/j.biopsych.2007.03.022. Epub 2007 Jun 27. Biol Psychiatry. 2008. PMID: 17586476
-
Sex differences in amphetamine-induced displacement of [(18)F]fallypride in striatal and extrastriatal regions: a PET study.Am J Psychiatry. 2006 Sep;163(9):1639-41. doi: 10.1176/ajp.2006.163.9.1639. Am J Psychiatry. 2006. PMID: 16946193
-
Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.Brain Res. 1986 Jun;396(2):157-98. doi: 10.1016/s0006-8993(86)80193-7. Brain Res. 1986. PMID: 3527341 Review.
-
The role of extrastriatal dopamine D2 receptors in schizophrenia.Biol Psychiatry. 2006 May 15;59(10):919-28. doi: 10.1016/j.biopsych.2006.01.022. Biol Psychiatry. 2006. PMID: 16682269 Review.
Cited by
-
In vivo long-lasting alterations of central serotonin transporter activity and associated dopamine synthesis after acute repeated administration of methamphetamine.EJNMMI Res. 2019 Sep 18;9(1):92. doi: 10.1186/s13550-019-0557-y. EJNMMI Res. 2019. PMID: 31535286 Free PMC article.
-
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.Eur J Nucl Med Mol Imaging. 2009 Mar;36(3):475-83. doi: 10.1007/s00259-008-0969-9. Epub 2008 Nov 5. Eur J Nucl Med Mol Imaging. 2009. PMID: 18985345 Clinical Trial.
-
Safety of Oral Amphetamine Administered during Positron Emission Tomography Scans in Medically Screened Humans.PLoS One. 2015 Dec 14;10(12):e0140647. doi: 10.1371/journal.pone.0140647. eCollection 2015. PLoS One. 2015. PMID: 26656737 Free PMC article.
-
The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding.Neuroimage. 2010 May 15;51(1):53-62. doi: 10.1016/j.neuroimage.2010.02.006. Epub 2010 Feb 10. Neuroimage. 2010. PMID: 20149883 Free PMC article.
-
18F-fallypride binding potential in patients with schizophrenia compared to healthy controls.Schizophr Res. 2010 Sep;122(1-3):43-52. doi: 10.1016/j.schres.2010.03.043. Epub 2010 Jul 23. Schizophr Res. 2010. PMID: 20655709 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical